Analysis of platelet inhibition function by measuring phosphorylation of the intracellular cytoskeleton protein VASP in whole blood over time
Open Access
- 13 December 2024
- journal article
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 23 (4) , 54-57
Abstract
The state of platelets may depend on the time since blood draw, primarily because of the presence of short-lived inhibitors of platelet activation in circulation. In this work, we analyzed the phosphorylation of vasodilator-stimulated phosphoprotein (VASP), which correlates with platelet inhibition, over time using flow cytometry. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. We investigated VASP phosphorylation in platelets in whole blood immediately after the blood was collected and 60 minutes later. As a positive control, we used platelet function inhibition by prostaglandin E1. As a result, it was found that the level of VASP phosphorylation in platelets in whole blood did not differ significantly in samples taken immediately after the blood draw and 60 minutes later, however it was markedly increased with platelet inhibition by prostaglandin E1. Our results suggest that the state of platelets does not change significantly within 60 minutes after the blood draw.Keywords
This publication has 16 references indexed in Scilit:
- Assessment of a flow cytometry technique for studying signaling pathways in platelets: Monitoring of VASP phosphorylation in clinical samplesPractical Laboratory Medicine, 2018
- Novel Strategies for Assessing Platelet ReactivityFuture Cardiology, 2016
- ‘VASPFix’ for measurement of VASP phosphorylation in platelets and for monitoring effects of P2Y12 antagonistsThrombosis and Haemostasis, 2014
- Platelets at work in primary hemostasisBlood Reviews, 2011
- A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometryThrombosis and Haemostasis, 2008
- Vasodilator‐stimulated phosphoprotein is a substrate for protein kinase CFEBS Letters, 2003
- Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in plateletsPlatelets, 2003
- Flow Cytometry Analysis of Intracellular VASP Phosphorylation for the Assessment of Activating and Inhibitory Signal Transduction Pathways in Human PlateletsThrombosis and Haemostasis, 1999
- Analysis and Regulation of Vasodilator-stimulated Phosphoprotein Serine 239 Phosphorylation in Vitro and in Intact Cells Using a Phosphospecific Monoclonal AntibodyJournal of Biological Chemistry, 1998
- Phosphorylation of Focal Adhesion Vasodilator‐Stimulated Phosphoprotein at Ser157 in Intact Human Platelets Correlates with Fibrinogen Receptor InhibitionEuropean Journal of Biochemistry, 1994